14.alpha., 17.alpha.-ethano-16.alpha.-hydroxy-estratrienes
US5529993A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Nov 29, 1990 |
| Grant date | Jun 25, 1996 |
| Priority date | — |
| Expiry date | Nov 29, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A 14.alpha.,17.alpha.-bridged estratriene of formula I ##STR1## wherein (a) OR.sup.3 is in .alpha.-position PA1 R.sup.1, R.sup.2 and R.sup.3, each independently are (i) hydrogen, (ii) ##STR2## in which R.sup.4 is an organic radical with up to 11 carbon atoms or (iii) --(CH.sub.2).sub.n COOH wherein n=1-4, or (iv) R.sup.1 is a benzyl, C.sub.1 -C.sub.8 alkyl or C.sub.3 -C.sub.5 cycloalkyl, or PA1 (b) OR.sup.3 is in .beta.-position PA1 R.sup.1, R.sup.2 and R.sup.3, each independently are (i) hydrogen, (ii) an acyl group with 1 to 12 carbon atoms or (iii) R.sup.1 is C.sub.1 -C.sub.8 alkyl, and in both (a) and (b) A--B is an etheno or ethano bridge.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.